You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0388 Effects of Blisibimod on Serum Immunoglobulins and Infection Risk in Patients with Systemic Lupus Erythematosus from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. SLE, Sjögren's and APS - treatment
FRI0388 Effects of Blisibimod on Serum Immunoglobulins and Infection Risk in Patients with Systemic Lupus Erythematosus from the Placebo-Controlled PEARL-SC and Open-Label Extension Studies

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014300
Jul 2014801
Aug 2014100
Sep 2014300
Oct 2014900
Nov 2014100
Dec 2014701
Jan 20151800
Mar 2015200
Apr 2015200
Jun 2015301
Jul 2015201
Aug 2015600
Sep 2015700
Nov 2015200
Dec 2015400
Jan 2016100
Feb 2016500
Mar 2016800
Apr 2016902
May 2016301
Jun 2016301
Jul 2016900
Aug 2016500
Sep 2016400
Oct 2016800
Nov 2016400
Dec 20161100
Jan 2017300
Feb 2017300
Mar 20171100
Apr 2017400
May 2017300
Jun 20171100
Jul 2017400
Aug 2017601
Sep 2017400
Oct 20171200
Nov 2017801
Dec 20171200
Jan 2018600
Feb 2018400
Mar 2018600
Apr 20181602
May 20181801
Jun 2018600
Jul 2018200
Aug 2018600
Sep 2018400
Oct 2018600
Nov 20181600
Dec 2018800
Feb 2019600
Apr 2019400
May 2019200
Aug 2019400
Dec 2019200
Feb 2020800
Mar 2020400
Apr 2020600
Jul 2020200
Sep 20201201
Oct 2020200
Nov 2020600
Dec 2020400
Feb 2021200
Mar 2021200
Apr 2021200
Aug 2021100
Oct 2021400
Dec 2021500
Jan 2022400
Feb 2022600
Mar 2022200
Apr 2022200
May 2022200
Jun 2022200
Jul 20221400
Aug 2022700
Sep 2022200
Oct 2022500
Nov 2022300
Dec 20221100
Jan 2023200
Feb 2023200
Mar 2023200
May 2023200
Jul 2023200
Aug 2023200
Sep 2023801
Nov 2023400
Dec 2023400
Jan 2024400
Mar 2024200
Total499015